Andrea Giani

Andrea Giani

Auto-generated profile, based on publicly available information

Andrea Giani

Retina Service, Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
EMErmengarda Marziani
Ermengarda Marziani
SPSimone Pomati
Simone Pomati
PRPaola Ramolfo
Paola Ramolfo
MCMario Cigada
Mario Cigada
AGAndrea Giani
Andrea Giani
GSGiovanni Staurenghi
Giovanni Staurenghi
Purpose. To evaluate differences between the retinal nerve fiber layer (RNFL) thickness and RNFL + ganglion cell layer (GCL) thickness in patients affected by Alzheimer's disease (AD) and healthy patients using spectral-domain optical coherence tomography (SD-OCT). Methods. This was a case-control prospective study. Twenty-one AD patients and 21 healthy subjects underwent neurological examination, clock-drawing test (CDT), Mini Mental State Examination (MMSE), and comprehensive ophthalmic evaluation with visual acuity. SD-OCT examination was performed using Spectralis and RTVue-100. An RNFL thickness map was obtained using the Spectralis volume protocol with 19 lines on the 30° field centered on the macula. On each B-scan, the outer RNFL limit was manually set. Statistical analysis was performed to assess interoperator RNFL evaluation thickness. An RNFL+GCL thickness map was obtained using the RTVue-100 MM6 protocol. Maps were divided into the nine ETDRS subfields and each map value in every area was evaluated. A single eye from each patient was randomly chosen to perform the analysis. Differences between AD and healthy subjects were assessed. Results. The two study groups were age and sex matched. MMSE results were 19.9 ± 3.1 and 27.9 ± 1.3, respectively (P < 0.001). There was good agreement in the manual delimitation of the RNFL layer. There was a significant difference in the thickness of both the RNFL and the RNFL+GCL in all examined fields. For example, in the inferior internal subfield, the RNFL thickness was 28.1 ± 3.1 μm for AD patients and 32.6 ± 3.8 μm for healthy subjects (P < 0.001). Conclusions. These results indicate that RNFL and RNFL+GCL thickness measurements are reduced in AD patients compared with healthy subjects. This finding may represent a useful element for the diagnosis and follow-up of this pathology.

16 August 2013 in Cell Death & Differentiation
Verified
Journal Article
Closed access
YMY Murakami
Y Murakami
HMH Matsumoto
H Matsumoto
MRM Roh
M Roh
AGA Giani
A Giani
KKK Kataoka
K Kataoka
DVDemetrios G. Vavvas
Demetrios G. Vavvas

1 December 2010 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
AGAndrea Giani
Andrea Giani
MCMario Cigada
Mario Cigada
NCNetan Choudhry
Netan Choudhry
ADAntonio Peroglio Deiro
Antonio Peroglio Deiro
MOMarta Oldani
Marta Oldani
GSGiovanni Staurenghi
Giovanni Staurenghi

9 May 2012 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
FBFerdinando Bottoni
Ferdinando Bottoni
ADAntonio Peroglio Deiro
Antonio Peroglio Deiro
AGAndrea Giani
Andrea Giani
COClaudia Orini
Claudia Orini
MCMario Cigada
Mario Cigada
GSGiovanni Staurenghi
Giovanni Staurenghi

1 May 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
AGAndrea Giani
Andrea Giani
ATAristomenis Thanos
Aristomenis Thanos
MRMi In Roh
Mi In Roh
ECEdward Connolly
Edward Connolly
GTGeorge Trichonas
George Trichonas
JMJoan Miller
Joan Miller
To describe the in vivo evolution of laser-induced choroidal neovascularization (CNV) in mice using spectral domain optical coherence tomography (SD-OCT). Laser photocoagulation was applied to the mouse fundus using a 532-nm diode laser (100, 150, and 200 mW; 100-μm diameter, 0.1-second duration). SD-OCT examination was performed immediately after laser application and at days 3, 5, 7, 14, 21, and 28 after laser. Fluorescein angiography (FA) was performed at day 5, 7, 14, and 28. Acquired SD-OCT images were analyzed to describe morphologic features, measure CNV size and retinal thickness, and assess the frequency of lesions resulting in fluid accumulation. Finally, SD-OCT images were compared to fluorescein angiograms and histologic sections with immunostaining at similar time points. SD-OCT allowed visualization of the initial laser damage and the subsequent stages of the injury response. CNV formation reached its maximum size at day 5. By day 7, significant size reduction was observed (P < 0.001), continuing through days 14 and 28. Exudation signs, such as fluid accumulation and increase in retinal thickness, followed the same time course, with a peak at day 5 and a decrease by day 7. Delivery of higher laser energy levels to the RPE/choroid complex resulted in a significant percentage of lesions demonstrating excessive chorioretinal damage without CNV formation. SD-OCT is a fast and reliable tool for the in vivo evaluation of laser-induced CNV, allowing quantification of lesion size and exudation parameters. Moreover, it provides morphologic information that correlates with histologic findings.

29 March 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMeredith S. Gregory
Meredith S. Gregory
CHCaroline G. Hackett
Caroline G. Hackett
EAEmma F. Abernathy
Emma F. Abernathy
KLKaren S. Lee
Karen S. Lee
RSRebecca R. Saff
Rebecca R. Saff
BKBruce R. Ksander
Bruce R. Ksander
Glaucoma, the most frequent optic neuropathy, is a leading cause of blindness worldwide. Death of retinal ganglion cells (RGCs) occurs in all forms of glaucoma and accounts for the loss of vision, however the molecular mechanisms that cause RGC loss remain unclear. The pro-apoptotic molecule, Fas ligand, is a transmembrane protein that can be cleaved from the cell surface by metalloproteinases to release a soluble protein with antagonistic activity. Previous studies documented that constitutive ocular expression of FasL maintained immune privilege and prevented neoangeogenesis. We now show that FasL also plays a major role in retinal neurotoxicity. Importantly, in both TNFα triggered RGC death and a spontaneous model of glaucoma, gene-targeted mice that express only full-length FasL exhibit accelerated RGC death. By contrast, FasL-deficiency, or administration of soluble FasL, protected RGCs from cell death. These data identify membrane-bound FasL as a critical effector molecule and potential therapeutic target in glaucoma.